Back-scattered electron imaging and elemental analysis of retrieved bone tissue following sinus augmentation with deproteinized bovine bone or biphasic calcium phosphate

Clin Oral Implants Res. 2010 Sep;21(9):924-30. doi: 10.1111/j.1600-0501.2010.01933.x. Epub 2010 May 9.

Abstract

Objectives: To compare resorption of a synthetic biphasic calcium phosphate (BCP) bone-graft substitute with deproteinized bovine bone (DBB) used for human maxillary sinus augmentation.

Materials and methods: Eleven patients underwent bilateral maxillary sinus floor augmentation with DBB in one side and a BCP (40%beta-tricalcium phosphate (beta-TCP) and 60% hydroxyapatite) in the contralateral side. Simultaneously, with the augmentation on each side a microimplant was placed vertically from the top of the alveolar crest penetrating the residual bone and the grafting material. Eight months after initial surgery the microimplants were retrieved with a surrounding bone core. The composition of residual graft material and surrounding bone was analysed by scanning electron microscopy and energy dispersive X-ray spectroscopy.

Results: Residual graft material of both types was present as 10-500 mum particles in direct contact with, or completely surrounded by, newly formed bone; smaller particles were also present in non-mineralized tissue. In the case of BCP the bone-graft substitute interface showed evidence of superficial disintegration of particles into individual grains. Median Ca/P ratios (at.%), determined from >200 discreet sites within residual graft particles and adjacent bone, were: DBB: 1.61 (confidence interval [CI] 1.59-1.64); BCP: 1.5 (CI 1.45-1.52); DBB-augmented bone: 1.62 (CI 1.59-1.66); BCP-augmented bone: 1.52 (CI 1.47-1.55); P=0.028 for DBB vs. BCP and DBB- vs. BCP-augmented bone. The reduction in Ca/P ratio for BCP over the healing period is consistent with the dissolution of beta-TCP and reprecipitation on the surface of calcium-deficient hydroxyapatite.

Conclusion: The beta-TCP component of BCP may be gradually substituted by calcium-deficient hydroxyapatite over the healing period. This process and superficial degranulation of BCP particles may influence the progress of resorption and healing.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Alveolar Ridge Augmentation / methods*
  • Animals
  • Biocompatible Materials / pharmacokinetics
  • Biocompatible Materials / therapeutic use*
  • Biotransformation
  • Bone Matrix / transplantation*
  • Bone Substitutes / pharmacokinetics
  • Bone Substitutes / therapeutic use*
  • Calcium / analysis
  • Calcium Phosphates / pharmacokinetics
  • Calcium Phosphates / therapeutic use*
  • Cattle
  • Chemical Precipitation
  • Collagen
  • Durapatite / pharmacokinetics
  • Durapatite / therapeutic use*
  • Female
  • Humans
  • Male
  • Maxilla / pathology
  • Maxilla / surgery
  • Maxillary Sinus / pathology
  • Maxillary Sinus / surgery*
  • Membranes, Artificial
  • Microscopy, Electron, Scanning
  • Middle Aged
  • Minerals / pharmacokinetics
  • Minerals / therapeutic use*
  • Osseointegration / physiology
  • Osteogenesis / physiology
  • Phosphorus / analysis
  • Scattering, Radiation
  • Solubility
  • Spectrometry, X-Ray Emission
  • Surface Properties

Substances

  • Bio-Gide
  • Bio-Oss
  • Biocompatible Materials
  • Bone Substitutes
  • Calcium Phosphates
  • Membranes, Artificial
  • Minerals
  • beta-tricalcium phosphate
  • Phosphorus
  • Collagen
  • Durapatite
  • Calcium